Skip to Content
Merck
  • Progesterone receptor induces bcl-x expression through intragenic binding sites favoring RNA polymerase II elongation.

Progesterone receptor induces bcl-x expression through intragenic binding sites favoring RNA polymerase II elongation.

Nucleic acids research (2013-05-04)
Paola Y Bertucci, A Silvina Nacht, Mariano Alló, Luciana Rocha-Viegas, Cecilia Ballaré, Daniel Soronellas, Giancarlo Castellano, Roser Zaurin, Alberto R Kornblihtt, Miguel Beato, Guillermo P Vicent, Adali Pecci
ABSTRACT

Steroid receptors were classically described for regulating transcription by binding to target gene promoters. However, genome-wide studies reveal that steroid receptors-binding sites are mainly located at intragenic regions. To determine the role of these sites, we examined the effect of progestins on the transcription of the bcl-x gene, where only intragenic progesterone receptor-binding sites (PRbs) were identified. We found that in response to hormone treatment, the PR is recruited to these sites along with two histone acetyltransferases CREB-binding protein (CBP) and GCN5, leading to an increase in histone H3 and H4 acetylation and to the binding of the SWI/SNF complex. Concomitant, a more relaxed chromatin was detected along bcl-x gene mainly in the regions surrounding the intragenic PRbs. PR also mediated the recruitment of the positive elongation factor pTEFb, favoring RNA polymerase II (Pol II) elongation activity. Together these events promoted the re-distribution of the active Pol II toward the 3'-end of the gene and a decrease in the ratio between proximal and distal transcription. These results suggest a novel mechanism by which PR regulates gene expression by facilitating the proper passage of the polymerase along hormone-dependent genes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-acetyl-Histone H4 (Lys12) Antibody, serum, Upstate®
Sigma-Aldrich
Anti-acetyl-Histone H3 (Lys18) Antibody, serum, Upstate®